These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 728293)

  • 1. The systemic availability of a slow release rectal preparation of lignocaine [proceedings].
    Beckett AH; Burgess CD; Johnston A; Warrington SJ
    Br J Clin Pharmacol; 1978 Nov; 6(5):442P-443P. PubMed ID: 728293
    [No Abstract]   [Full Text] [Related]  

  • 2. Rectal bioavailability of lidocaine in rats: absence of significant first-pass elimination.
    de Boer AG; Breimer DD; Pronk J; Gubbens-Stibbe JM
    J Pharm Sci; 1980 Jul; 69(7):804-7. PubMed ID: 7391945
    [No Abstract]   [Full Text] [Related]  

  • 3. First-pass elimination of lidocaine in the rabbit after peroral and rectal route of administration.
    Ritschel WA; Elconin H; Alcorn GJ; Denson DD
    Biopharm Drug Dispos; 1985; 6(3):281-90. PubMed ID: 4041555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The study of the bioavailability of coated acetylsalicylic acid in suppositories after rectal administration.
    Stozek T
    Pol J Pharmacol Pharm; 1975; 27(2):227-33. PubMed ID: 1153355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets.
    Kaiko RF; Fitzmartin RD; Thomas GB; Goldenheim PD
    Pharmacotherapy; 1992; 12(2):107-13. PubMed ID: 1570227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drugs for rectal administration (a review of the literature)].
    Golovkin VA; Peshekhonova LL; Lukash EP
    Vrach Delo; 1984 Nov; (11):7-11. PubMed ID: 6396948
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.
    Perucca E; Richens A
    Br J Clin Pharmacol; 1979 Jul; 8(1):21-31. PubMed ID: 552293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of placebo and intrauterine lidocaine with/or without rectal diclofenac sodium suppositories used in office endometrial biopsy.
    Kaya C; Sener EB; Koksal E; Ustun YB; Celik H; Sahinoglu AH
    J Pak Med Assoc; 2015 Jan; 65(1):29-34. PubMed ID: 25831670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of lignocaine gel-soaked Falope rings vs rectal diclofenac suppository for pain relief in laparoscopic sterilization.
    Sharma JB; Ghosh B; Kumar P; Mittal S; Kumar S; Roy KK
    J Minim Invasive Gynecol; 2011; 18(1):43-7. PubMed ID: 21094099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal bioavailability of lidocaine in man: partial avoidance of "first-pass" metabolism.
    de Boer AG; Breimer DD; Mattie H; Pronk J; Gubbens-Stibbe JM
    Clin Pharmacol Ther; 1979 Dec; 26(6):701-9. PubMed ID: 498711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
    Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T
    Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823
    [No Abstract]   [Full Text] [Related]  

  • 12. Biopharmaceutical investigations of rectal suppositories. Part 1: Pharmaceutical and biological availability of theophylline.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1984 Apr; 39(4):242-3. PubMed ID: 6547533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
    Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K
    Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103
    [No Abstract]   [Full Text] [Related]  

  • 14. Rectal bioavailability of lidocaine in the dog: evaluation of first-pass elimination.
    Ritschel WA; Grummich KW; Hussain AS; Denson DD; Ritschel BE
    Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):497-502. PubMed ID: 3695734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lignocaine suppositories for migraine.
    Lewis GB
    Anaesth Intensive Care; 1992 Nov; 20(4):533-4. PubMed ID: 1463194
    [No Abstract]   [Full Text] [Related]  

  • 16. Biopharmaceutical investigation of rectal suppositories. Part 2(1): Pharmaceutical and biological availability of phenobarbital and phenobarbital-sodium.
    Minkov E; Lambov N; Kirchev D; Bantutova I; Tencheva J
    Pharmazie; 1985 Apr; 40(4):257-9. PubMed ID: 3839310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo studies on slow release propranolol hydrochloride suppositories. Pharmacokinetic and pharmacodynamic evaluation.
    Sastri MS; Satyanarayana NV; Krishna DR; Diwan PV
    Arzneimittelforschung; 1993 Mar; 43(3):320-3. PubMed ID: 8489559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avoidance of "first-pass" elimination of rectally administered lidocaine in relation to the site of absorption in rats.
    de Leede LG; de Boer AG; Roozen CP; Breimer DD
    J Pharmacol Exp Ther; 1983 Apr; 225(1):181-5. PubMed ID: 6834271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of dibucaine from konjac gels after rectal administration to rats.
    Nakano M; Takikawa K; Arita T
    Chem Pharm Bull (Tokyo); 1979 Oct; 27(10):2501-3. PubMed ID: 527137
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathways of paracetamol absorption from layered excipient suppositories: artificial intelligence approach.
    Belic A; Grabnar I; Karba R; Mrhar A
    Eur J Drug Metab Pharmacokinet; 2003; 28(1):31-40. PubMed ID: 14503662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.